{{Rsnum
|rsid=10263639
|Chromosome=7
|position=67594280
|Orientation=plus
|GMAF=0.1538
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 2.7 | 31.9 | 65.5
| HCB | 0.0 | 19.0 | 81.0
| JPT | 3.5 | 14.2 | 82.3
| YRI | 2.0 | 23.8 | 74.1
| ASW | 5.3 | 22.8 | 71.9
| CHB | 0.0 | 19.0 | 81.0
| CHD | 0.0 | 12.8 | 87.2
| GIH | 1.0 | 19.8 | 79.2
| LWK | 1.8 | 40.0 | 58.2
| MEX | 1.7 | 43.1 | 55.2
| MKK | 8.3 | 34.6 | 57.1
| TSI | 3.9 | 24.5 | 71.6
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=17903305
|Trait=Breast cancer
|Title=A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study
|RiskAllele=
|Pval=0.0000030000000000000001
|OR=NR
|ORtxt=NR
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10263639
|overall_frequency_n=21
|overall_frequency_d=128
|overall_frequency=0.164062
|n_genomes=14
|n_genomes_annotated=0
|n_haplomes=16
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=2
|webscore=N
|n_web_uneval=9
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}